References
1. Babu KSD, Janakiraman V, Palaniswamy H, et al. A short review on sugarcane: its domestication, molecular manipulations and future perspectives. Genet Resour Crop Evol 2022;69:2623–2643.
3. Hwang L-D, Zhu G, Breslin PAS, et al. A common genetic influence on human intensity ratings of sugars and high-potency sweeteners. Twin Res Hum Genet 2015;18:361–367.
4. Mooradian AD, Smith M, Tokuda M. The role of artificial and natural sweeteners in reducing the consumption of table sugar: a narrative review. Clin Nutr ESPEN 2017;18:1–8.
5. World Health Organization. Healthy diet. https://www.who.int/news-room/factsheets/detail/healthy-diet#:~:text=Less%20than%2010%25%20of%20total% 20energy%20intake%20from%20free%20sugars,additional%20health% 20benefits%20(7). Published April 29, 2020. Accessed February 1, 2024.
6. US Department of Agriculture; US Department of Health and Human Services. Dietary guidelines for Americans.
https://www.dietaryguidelines.gov/. Accessed February 1, 2024.
7. Stamataki NS, Scott C, Elliott R, et al. Stevia beverage consumption prior to lunch reduces appetite and total energy intake without affecting glycemia or attentional bias to food cues: a double-blind randomized controlled trial in healthy adults. J Nutr 2020;150:1126–1134.
8. Swithers SE. Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements. Trends Endocrinol Metab 2013;24:431–441.
9. Lindseth GN, Coolahan SE, Petros TV, et al. Neurobehavioral effects of aspartame consumption. Res Nurs Health 2014;37:185–193.
10. Walton RG, Hudak R, Green-Waite RJ. Adverse reactions to aspartame: double-blind challenge in patients from a vulnerable population. Biol Psychiatry 1993;34:13–17.
11. Berry C, Brusick D, Cohen SM, et al. Sucralose non-carcinogenicity: a review of the scientific and regulatory rationale. Nutr Cancer 2016;68:1247–1261.
12. Arroyo-Quiroz C, Brunauer R, Alavez S. Sugar-sweetened beverages and cancer risk: a narrative review. Nutr Cancer 2022;74:3077–3095.
13. Chazelas E, Srour B, Desmetz E, et al. Sugary drink consumption and risk of cancer: results from NutriNet-Santé prospective cohort. BMJ 2019:366:l2408.
14. Witkowski M, Nemet I, Alamri H, et al. The artificial sweetener erythritol and cardiovascular event risk. Nat Med 2023;29:710–718.
15. Mossavar-Rahmani Y, Kamensky V, Manson JE, et al. Artificially sweetened beverages and stroke, coronary heart disease, and all-cause mortality in the Women’s Health Initiative. Stroke 2019;50:555–562.
16. Chazelas E, Debras C, Srour B, et al. Sugary drinks, artificially-sweetened beverages, and cardiovascular disease in the NutriNet-Sante cohort. J Am Coll Cardiol 2020;76:2175–2177.
17. Malik VS, Li Y, Pan A, et al.. Long-term consumption of sugar-sweetened and artificially sweetened beverages and risk of mortality in US adults. Circulation 2019;139:2113–2125.
18. McGlynn ND, Khan TA, Wang L, et al. Association of low- and no-calorie sweetened beverages as a replacement for sugar-sweetened beverages with body weight and cardiometabolic risk: a systematic review and metaanalysis. JAMA Netw Open 2022;5:e222092.
20. Aspartame hazard and risk assessment results released.
https://www.who.int/. Accessed June 6, 2024.
21. Franchi F, Yaranov DM, Rollini F, et al. Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective randomized, crossover study. BMJ Open Diabetes Res Care 2021;9:e001939.
22. Mooradian AD, Haas MJ, Onstead-Haas L, et al. Naturally occurring rare sugars are free radical scavengers and can ameliorate endoplasmic reticulum stress. Int J Vitam Nutr Res 2020;90:210–220.
23. Daniel H, Hauner H, Hortnef M, et al. Allulose in human diet: the knowns and the unknowns. Br J Nutr 2022;128:172–178.
24. Haas MJ, Parekh S, Kalidas P, et al. Insulin mimetic effect of D-allulose on apolipoprotein A-I gene. J Food Biochem 2022;46:e14064.
25. Mooradian AD, Haas MJ. Targeting high density lipoproteins: increasing de novo production vs. decreasing clearance. Drugs 2015;75:713–722.
26. St-Pierre P, Pilon G, Dumais V, et al. Comparative analysis of maple syrup to other natural sweeteners and evaluation of their metabolic responses in healthy rats. J Funct Foods 2014;11:460–471.
27. Wan C, Yuan T, Li L, et al. Maplexins, new α-glucosidase inhibitors from red maple (Acer rubrum) stems. Bioorg Med Chem Lett 2012; 22:597–600.
28. Mohammed, F, Sibley P, Abdulwali N, et al. Nutritional, pharmacological, and sensory properties of maple syrup: a comprehensive review. Heliyon 2023;9:e19216.
29. Mooradian AD. In search for an alternative to sugar to reduce obesity. Int J Vitam Nutr Res 2019;89:113–117. .
30. Reyes MM, Castura JC, Hayes JE. Characterizing dynamic sensory properties of nutritive and nonnutritive sweeteners with temporal check-allthat-apply. J Sens Stud 2017;32:e12270.
31. Joseph JA, Akkermans S, Nimmegeers P, et al. Bioproduction of the recombinant sweet protein thaumatin: current state of the art and perspectives. Front Microbiol 2019;10:695.